semaglutide cardiovascular outcomes news HUGE NEWS! Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetics, they REDUCE risk of death, heart attack, stroke, heart failure, AND ALL CAUSE MORTALITY! Groundbreaking SELECT Weight loss and cardiovascular disease

Organizations need to understand not just what they spent on GLP-1s last quarter, but which members are driving utilization, whether formulary controls are working, and where costs are heading next

There is no recovery pain otherwise, and most patients go straight back to work or to the gym the same day, avoiding only intense upper-body exercise on the treated arm for a few hours

Only L and no ava 2 C were detected in both cases (Supplementary Fig

Achieving an RVR is highly predictive of obtaining an SVR independent of genotype and regardless of the treatment regimen

Conclusion: A Small Step for Accurate Health Insights Fasting for a blood test may seem like a minor inconvenience, but it is one of the most important steps in your healthcare journey